Close

Tag: Drug

LINDIS Biotech Partners with Celonic for Production and Commercial Supply of Catumaxomab

LINDIS Biotech has received EMA Marketing Authorisation for catumaxomab, making it the only medicine licensed for the targeted and cancer-directed therapy of malignant...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read